Integrated cancer cell-specific single-cell RNA-seq datasets of immune checkpoint blockade-treated patients
Abstract Immune checkpoint blockade (ICB) therapies have emerged as a promising avenue for the treatment of various cancers. Despite their success, the efficacy of these treatments is variable across patients and cancer types. Numerous single-cell RNA-sequencing (scRNA-seq) studies have been conduct...
Saved in:
Main Authors: | Mahnoor N. Gondal, Marcin Cieslik, Arul M. Chinnaiyan |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | Scientific Data |
Online Access: | https://doi.org/10.1038/s41597-025-04381-6 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Integration of bulk and single-cell RNA-seq reveals prognostic gene signatures in patients with bladder cancer treated with immune checkpoint inhibitors
by: Mina Cho, et al.
Published: (2024-12-01) -
Blood-based biomarkers in patients with non-small cell lung cancer treated with immune checkpoint blockade
by: Yo-Ting Tsai, et al.
Published: (2024-03-01) -
Immune Checkpoint Blockade in Melanoma – Earlier is Better?
by: Vincas Urbonas, et al.
Published: (2024-09-01) -
Sequentially Activated Smart DNA Nanospheres for Photoimmunotherapy and Immune Checkpoint Blockade
by: Yu Chen, et al.
Published: (2025-01-01) -
Pan-tumor analysis to investigate the obesity paradox in immune checkpoint blockade
by: Evan J Lipson, et al.
Published: (2025-01-01)